How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Mouse Model Services Market
- By Service Type: Transgenic Mouse Model Generation, Knockout Mouse Model Generation, CRISPR/Cas9 Gene Editing, Conditional Knockout Models, Humanized Mouse Models, Phenotyping Services
- By Model Type: Inbred Mouse Models, Outbred Mouse Models, Genetically Engineered Mouse Models (GEMMs), Patient-Derived Xenograft (PDX) Models, Humanized Mouse Models
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Government and Non-Profit Research Organizations
- By Application: Oncology Research, Immunology Research, Neuroscience Research, Cardiovascular Research, Metabolic Disease Research, Infectious Disease Research
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Transgenic Mouse Model Generation leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 282 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 14 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Mouse Model Services Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Service Type 6
Model Type 5
End User 4
Application 6
Companies profiled
Charles River Laboratories International Inc.
Envigo RMS (a part of Inotiv)
Taconic Biosciences Inc.
The Jackson Laboratory
Crown Bioscience Inc.
Cyagen Biosciences Inc.
GemPharmatech Co. Ltd.
Shanghai Model Organisms Center Inc.
Biocytogen Pharmaceuticals (Beijing) Co. Ltd.
Harlan Laboratories (now part of Envigo)
Oriental BioService Inc.
Transgenic Inc.
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Charles River Laboratories International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Envigo RMS (a part of Inotiv)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Taconic Biosciences Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →The Jackson Laboratory
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Crown Bioscience Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Cyagen Biosciences Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →GemPharmatech Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Shanghai Model Organisms Center Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Biocytogen Pharmaceuticals (Beijing) Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Harlan Laboratories (now part of Envigo)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Oriental BioService Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Transgenic Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →GenOway SA
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Model Animal Research Center of Nanjing University
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$8,665M by 2033 · 10.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Transgenic Mouse Model Generation37.0
- Knockout Mouse Model Generation13.2
- CRISPR/Cas9 Gene Editing9.7
- Conditional Knockout Models16.0
- Humanized Mouse Models17.2
- Phenotyping Services7.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,337M → $2,634M · 8.8%
Europe$931.9M → $1,986M · 9.9%
Asia Pacific$850.9M → $1,793M · 9.8%
Latin America$526.7M → $1,097M · 9.6%
Middle East and Africa$405.2M → $913.6M · 10.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.932026
9.922027
9.942028
9.952029
9.962030
9.982031
9.992032
10.012033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Charles River Laboratories International Inc.13.7
- Envigo RMS (a part of Inotiv)10.8
- Taconic Biosciences Inc.10.2
- The Jackson Laboratory9.6
- Crown Bioscience Inc.15.3
- Cyagen Biosciences Inc.12.3
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type36.1%
Model Type22.3%
End User25.5%
Application16.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.3
- Europe23.6
- Asia Pacific21.3
- Latin America13.0
- Middle East and Africa10.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Charles River Laboratories International Inc. | 82 | 96 | 85 | 90 | 94 | 82 | 88 |
| Envigo RMS (a part of Inotiv) | 85 | 79 | 87 | 81 | 68 | 71 | 79 |
| Taconic Biosciences Inc. | 66 | 69 | 82 | 76 | 74 | 70 | 73 |
| The Jackson Laboratory | 81 | 77 | 61 | 59 | 67 | 63 | 68 |
| Crown Bioscience Inc. | 55 | 72 | 68 | 68 | 63 | 60 | 64 |
| Cyagen Biosciences Inc. | 48 | 54 | 51 | 48 | 50 | 62 | 52 |
| GemPharmatech Co. Ltd. | 53 | 48 | 50 | 45 | 64 | 44 | 51 |
| Shanghai Model Organisms Center Inc. | 51 | 54 | 47 | 35 | 39 | 40 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Charles River Laboratories International Inc.
- Envigo RMS (a part of Inotiv)
- Taconic Biosciences Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Charles River Laboratories International Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Envigo RMS (a part of Inotiv) | ✓ | ◐ | ◐ | ◐ | ✓ | ✓ |
| Taconic Biosciences Inc. | − | ✓ | ✓ | ✓ | ◐ | ◐ |
| The Jackson Laboratory | ✓ | ◐ | − | ◐ | ◐ | ◐ |
| Crown Bioscience Inc. | − | − | − | ◐ | ✓ | − |
| Cyagen Biosciences Inc. | − | − | − | − | − | ◐ |
| GemPharmatech Co. Ltd. | − | − | − | − | ◐ | − |
| Shanghai Model Organisms Center Inc. | ◐ | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Charles River Laboratories International Inc.88
2Envigo RMS (a part of Inotiv)79
3Taconic Biosciences Inc.73
4The Jackson Laboratory68
5Crown Bioscience Inc.64
6Cyagen Biosciences Inc.52
7GemPharmatech Co. Ltd.51
8Shanghai Model Organisms Center Inc.44
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Charles River Laboratories International Inc.Envigo RMS (a part of Inotiv)
Challenger2
Strong scale, closing on the leaders.
Taconic Biosciences Inc.The Jackson Laboratory
Contender1
Focused players with pockets of strength.
Crown Bioscience Inc.
Niche3
Specialists in a single segment or region.
Cyagen Biosciences Inc.GemPharmatech Co. Ltd.Shanghai Model Organisms Center Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Mouse Model Services Market — a $395M beachhead inside a $6.50B market.
Beachhead (SOM)$395Mobtainable near-term
Serviceable (SAM)$2.67Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Transgenic Mouse Model Generation
Best fit — highest urgency & budget in Service Type.
Economic buyer78 fit
Knockout Mouse Model Generation
Strong fit — clear ROI and a fast path to value.
End user67 fit
CRISPR/Cas9 Gene Editing
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Model Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel26%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Mouse Model Services Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified22%
Evaluation14%
Closed-won8%
$8.3KCAC
$36KLTV
4.4:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Mouse Model Services Market is a durable-growth opportunity — $6.24B by 2033, compounding at 8.3%.
TAM · 2025$3.30Btoday
TAM · 2033$6.24Bforecast
CAGR8.3%2027–2033
Cumulative$41.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.24BTotal addressable market
SAM$2.44BServiceable available market
SOM$432MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.3% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.24BLarge & growingTAM by 2033 at 8.3% CAGR
$2.44BServiceable nowreachable with today’s model
$432MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.86BBear5.4% CAGR
$6.24BBase8.3% CAGR
$7.98BBull10.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Model Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Mouse Model Services Market — a $4.08B market by 2033. Plan: grow share from 8.0% to 14.1%.
Market size · 2033$4.08Btotal addressable
Market CAGR6.8%2027–2033
Target share14.1%from 8.0% today
Revenue ambition$576Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.0% | 14.1% | On track |
| Revenue | $325M | $576M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 28.6% | 44.2% | Behind |
| Customer retention | 91.4% | 96.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Model Type capability
A defensible second engine — invest in Model Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Model Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $67M capacity & capability investment
- Greenlight bolt-on M&A in Model Type
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Mouse Model Services Market conversation — a $5.95B market you can size, segment and defend in minutes.
Market size · 2033$5.95Btotal opportunity
Growth5.1%CAGR to 2033
Addressable buyers1,485+accounts in scope
Typical ROI4.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.5×return on cost, year one
< 3 mopayback period
$87K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Charles River Laboratories International Inc.Envigo RMS (a part of Inotiv)Taconic Biosciences Inc.The Jackson LaboratoryCrown Bioscience Inc.Cyagen Biosciences Inc.GemPharmatech Co. Ltd.Shanghai Model Organisms Center Inc.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Mouse Model Services Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Mouse Model Services Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Preventive Vaccines Market
Market size, share, segmentation and regional forecast.
$648M market · 2025 base year
View reportPreventive Asthma Drug Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportPreventable Vaccines Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportPotassium Channel Blocker Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportMemory Enhancement Drugs Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportPolyoxidonium Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportPlatelet-rich Plasma Therapy Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportPhytoestrogen Supplements Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportPhysiological Measurement Capsule Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportAir Sterilizer Market
Market size, share, segmentation and regional forecast.
$826M market · 2025 base year
View reportPhysician Dispensed Skin Care Products Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportAir Sterilizer for Hospital Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.